Doorgaan naar hoofdnavigatie Doorgaan naar zoeken Ga verder naar hoofdinhoud

The feasibility of using real world data as external control arms in oncology trials

  • Lishi Lin
  • , Merel J.J. Lucassen
  • , Vincent van der Noort
  • , Toine C.G. Egberts
  • , Jos H. Beijnen
  • , Alwin D.R. Huitema

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

6 Citaten (Scopus)

Samenvatting

Before real world data (RWD)-derived external control arms (ECAs) can be applied in clinical trials within the field of oncology, it must be determined whether these ECAs can function as appropriate and reliable control arms. This review provides an overview of studies in which RWD-derived ECAs were constructed and compared to a randomized clinical trial (RCT) arm. RWD-derived ECAs had similar survival outcomes as the RCT arm of comparison in six of the eight included studies. Therefore, when performing RCTs is not feasible, RWD-derived ECAs can act as control arms in single-arm clinical trials, provided that suitable RWD sources are used and suitable methodological decisions are made.

Originele taal-2Engels
Artikelnummer104324
Pagina's (van-tot)104324
TijdschriftDrug Discovery Today
Volume30
Nummer van het tijdschrift3
DOI's
StatusGepubliceerd - mrt. 2025

Vingerafdruk

Duik in de onderzoeksthema's van 'The feasibility of using real world data as external control arms in oncology trials'. Samen vormen ze een unieke vingerafdruk.

Citeer dit